Skip to main content
Journey Medical Corp logo

Journey Medical Corp — Investor Relations & Filings

Ticker · DERM ISIN · US48115J1097 US Manufacturing
Filings indexed 201 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US DERM

About Journey Medical Corp

https://journeymedicalcorp.com/

Journey Medical Corp. is a commercial-stage pharmaceutical company focused on developing and commercializing products for dermatological conditions. The company's business model centers on strategically identifying, acquiring, and marketing innovative and differentiated therapies to address unmet needs in skin health. Its product portfolio targets a range of conditions, including acne, rosacea, axillary hyperhidrosis (excessive sweating), fungal infections, and skin wounds. Marketed products in its portfolio include Qbrexza, Accutane, Amzeeq, and Zilxi. The company is committed to providing effective treatments that positively impact the well-being of patients with skin-related issues.

Recent filings

Filing Released Lang Actions
10-Q - Journey Medical Corp (0001867066) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
8-K - Journey Medical Corp (0001867066) (Filer)
Regulatory Filings
2026-04-21 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) under the Securities Act of 1933, related to an at-the-market equity offering of common stock. It includes detailed information about the offering, the company, risk factors, use of proceeds, dilution, and plan of distribution. This type of document is a capital raising disclosure, specifically a prospectus supplement for a stock offering. It is not an annual or quarterly report, earnings release, or management discussion. It is a financing update related to the issuance of new shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2026-01-23 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) under a shelf registration statement (Form S-3) with the SEC. It details the offering of up to $150 million in securities including common stock, preferred stock, debt securities, warrants, and units. The text includes descriptions of the securities, risk factors, use of proceeds, and plan of distribution. It is not a financial report, earnings release, or management discussion, but rather a capital raising document describing the terms and conditions of securities offerings. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document length is substantial and contains detailed offering information, not just an announcement or summary, so it is not an RPA or RNS. Therefore, the correct classification is CAP.
2026-01-23 English
Regulatory Filings 2026
Regulatory Filings
2026-01-22 English
FORM S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for public offering. It includes a base prospectus and a sales agreement prospectus for offerings of common stock, preferred stock, debt securities, warrants, and units. The document is not a financial report, earnings release, or management discussion, but rather a capital raising filing that registers securities for sale. It is not an announcement of a report but the actual registration statement itself, which is a regulatory filing related to capital markets activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration and offering information, consistent with a capital/financing update filing.
2026-01-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.